tiprankstipranks
TipRanksStock Market NewsARGX NewsAnalysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and US Physical Therapy (USPH)
Blurbs

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and US Physical Therapy (USPH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGXResearch Report) and US Physical Therapy (USPHResearch Report) with bullish sentiments.

Argenx Se (ARGX)

In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Argenx Se, with a price target of $362.00. The company’s shares closed last Thursday at $320.34.

According to TipRanks.com, Tewari is a 4-star analyst with an average return of 19.5% and a 52.8% success rate. Tewari covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Zentalis Pharmaceuticals, and BioMarin Pharmaceutical.

Argenx Se has an analyst consensus of Strong Buy, with a price target consensus of $374.78, a 22.5% upside from current levels. In a report issued on May 3, Morgan Stanley also upgraded the stock to Buy with a $375.00 price target.

See the top stocks recommended by analysts >>

US Physical Therapy (USPH)

Jefferies analyst Stephanie Wissink maintained a Buy rating on US Physical Therapy yesterday and set a price target of $140.00. The company’s shares closed last Thursday at $103.26.

According to TipRanks.com, Wissink is a 2-star analyst with an average return of -0.1% and a 44.2% success rate. Wissink covers the Consumer Goods sector, focusing on stocks such as The Estée Lauder Companies, National Vision Holdings, and Natura & Co Holding.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for US Physical Therapy with a $131.50 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ARGX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More